Dr. Sasson Moulavi Discusses Benefits of Smart for Life’s
Unique New Product Category
Miami, FL – April 26, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has released a video showcasing the benefits of the Company’s new high protein ice cream. The video interview features Dr. Sasson E. Moulavi (Dr. Sass), Chief Medical Officer of Smart for Life and developer of the R&D initiatives behind the Company’s innovative high protein ice cream products.
“Fueled by my background in the field of medicine and my own weight loss journey, I have spent the bulk of my professional career addressing weight loss issues and developing clinically proven products at Smart for Life that are balanced, nutritious and healthy,” stated Dr. Sass. “Having conducted extensive R&D development for the past 3 years, I am pleased to unveil our new proprietary ice cream bars that are packed with high-quality protein, fiber, and essential nutrients. This formula also helps to regulate blood sugar levels, reducing risk of insulin resistance and type 2 diabetes. I believe our high protein ice cream bars represent an entirely new category, and I’m excited to extoll their benefits as we expand our launch in local markets across the nation.”
Smart for Life’s video featuring Dr. Sasson Moulavi can be found here:
www.smartforlifecorp.com/2023/04/20/dr-sass-protein-ice-cream
About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.
The company’s previously issued letter to shareholders is available at: www.smartforlifecorp.com/2023/01/12/smart-for-life-ceo-issues-year-end-letter-to-shareholders/.
The Company recently released a video report from A.J. Cervantes, Jr., the Company’s Chairman. That report can be accessed here: https://smartforlifecorp.com/2023/04/02/chairmans-video-report/
Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.
Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.
Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.
Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com